Aged *Diet Dietary Fiber/*administration & dosage Female Humans Male Middle Aged Prospective Studies Risk Factors Urinary Bladder Neoplasms/*prevention & control *Whole Grains bladder cancer cohort study dietary fiber dose-response analysis grain

Aged *Brachytherapy Combined Modality Therapy Disease-Free Survival Female Humans Male Middle Aged Neoplasm Recurrence Local *Urinary Bladder Neoplasms/mortality/pathology/radiotherapy external beam radiotherapy interstitial brachytherapy muscle-invasive bladder cancer organ preservation

Aged Biomarkers/*blood C-Reactive Protein/analysis Cystectomy/*methods Female Humans Leukocyte Count Lymphocytes/pathology Male Middle Aged Neutrophils/pathology Platelet Count Preoperative Period Prognosis Proportional Hazards Models Retrospective Studies Urinary Bladder Neoplasms/blood/*mortality/*surgery Hematologic biomarker Meta-analysis Urothelial carcinoma of the bladder

Age of Onset Cohort Studies Female Hormones/*metabolism Humans Menopause Middle Aged Parity Prospective Studies *Reproduction Risk Assessment Risk Factors United States/epidemiology Urinary Bladder Neoplasms/epidemiology/*physiopathology Plco bladder cancer hormones meta-analysis reproductive factors interest.

Adult Caffeine/*adverse effects Central Nervous System Stimulants/adverse effects Coffee/*adverse effects Cytochrome P-450 CYP1A2 Dose-Response Relationship Drug Female Humans Male Middle Aged Risk Factors Smoking/*adverse effects Urinary Bladder Neoplasms/*etiology Bladder cancer Coffee consumption Cohort study Dose–response analyses Smoking

Chemotherapy Adjuvant *Combined Modality Therapy Cystectomy Female Humans Middle Aged Muscles Neoadjuvant Therapy *Neoplasm Invasiveness Organ Sparing Treatments Patient Selection Quality of Life Salvage Therapy Survival Rate *Urinary Bladder Neoplasms/therapy

Aged Catheterization Female Hospitalization Humans Lasers Solid-State/*therapeutic use Male Middle Aged Muscles/*pathology Neoplasm Recurrence Local/pathology Postoperative Complications/etiology Publication Bias Treatment Outcome Urethral Stricture/surgery Urinary Bladder Neoplasms/pathology/*surgery *Urologic Surgical Procedures Holmium laser Meta-analysis Non-muscle-invasive bladder cancer Transurethral resection

Adult Aged Aged 80 and over B7-H1 Antigen/genetics/*immunology Female Humans Immune Checkpoint Inhibitors/*administration & dosage *Immunotherapy Male Middle Aged Programmed Cell Death 1 Receptor/genetics/*immunology Progression-Free Survival Randomized Controlled Trials as Topic Treatment Outcome Urinary Bladder Neoplasms/genetics/immunology/mortality/*therapy efficacy immunotherapy meta-analysis safety urothelial cancer this study.

Adult Aged Aged 80 and over Female Humans Male Middle Aged Urinary Bladder Neoplasms/*radiotherapy Bladder neoplasm Bladder preservation Cis Chemoradiotherapy Radiotherapy T1 Bladder cancer

Adult Aged Aged 80 and over Female *Health Services Needs and Demand Humans Male Middle Aged Sexual Dysfunction Physiological/*etiology *Sexual Health Urinary Bladder Neoplasms/*complications/*therapy Bladder cancer Health-related quality of life Mental wellbeing Radical cystectomy Sexual health

Aged Carcinoma Transitional Cell/*surgery *Cystectomy/methods Female Humans *Lymph Node Excision Male Middle Aged Postoperative Complications Randomized Controlled Trials as Topic Treatment Outcome Urinary Bladder Neoplasms/*surgery

Adult Aged Air Pollution/*adverse effects Carcinogens Environmental/*adverse effects Cohort Studies Environmental Exposure/*adverse effects Europe/epidemiology Female Humans Incidence Male Meta-Analysis as Topic Middle Aged Nitrogen Oxides/adverse effects Particulate Matter/adverse effects Prospective Studies Risk Factors Urinary Bladder Neoplasms/*epidemiology/etiology Air pollution Bladder cancer Environment Prevention

Adult Aged Aged 80 and over Cystectomy/methods/mortality Female Humans Hydronephrosis/*physiopathology/surgery Male Middle Aged Neoplasm Staging Prognosis Proportional Hazards Models Retrospective Studies Urinary Bladder/pathology Urinary Bladder Neoplasms/*complications/*pathology

Abdominal Muscles/*physiopathology Female *Health Services Needs and Demand Humans Middle Aged Neoplasm Metastasis/*physiopathology Quality of Life/*psychology *Social Support Urinary Bladder Neoplasms/*psychology/*secondary/therapy Bladder cancer Concerns Continent diversion Quality of life Systematic review Unmet supportive care needs

Adult Aged Aged 80 and over Checklist Consensus Databases Factual Female Humans Male Middle Aged *Patient Reported Outcome Measures Psychometrics/methods/*standards Surveys and Questionnaires/*standards *Urinary Bladder Neoplasms Cosmin bladder cancer patient reported outcome measures psychometric properties systematic review

Female *Health Status Humans Male Middle Aged *Quality of Life Surveys and Questionnaires Treatment Outcome Urinary Bladder/*surgery Urinary Bladder Neoplasms/*surgery Urinary Diversion/*methods Urinary Reservoirs Continent Bladder cancer Meta-analysis Quality of life Urinary diversion

Adolescent Adult Aged Aged 80 and over Animals Cultured Milk Products *Dairy Products *Diet Dietary Fats/administration & dosage *Feeding Behavior Female Humans Male Middle Aged Milk *Urinary Bladder Neoplasms/etiology/prevention & control Young Adult dairy products fermented dairy products whole milk bladder cancer meta-analysis systematic review

Aged Biomarkers Tumor/*blood Cystectomy/*adverse effects Female Humans Leukocyte Count Lymphocytes/*pathology Male Middle Aged Monocytes/*pathology Neoplasm Recurrence Local/blood/*epidemiology Postoperative Complications/blood/*epidemiology Survival Analysis Urinary Bladder Neoplasms/*blood/pathology/surgery

Administration Intravesical Aged Aged 80 and over BCG Vaccine/*therapeutic use Biopsy Needle Disease-Free Survival Female Humans Immunohistochemistry Immunotherapy/*methods In Situ Hybridization Fluorescence Male Middle Aged Neoplasm Recurrence Local/mortality/*pathology Predictive Value of Tests Prognosis Risk Assessment Survival Analysis Treatment Outcome Urinary Bladder Neoplasms/mortality/pathology/*therapy Bcg Bladder cancer Immunotherapy Personalized therapy Response prediction

Adult Aged Aged 80 and over Female Humans *Magnetic Resonance Imaging Male Middle Aged *Neoplasm Staging/methods/standards Urinary Bladder Neoplasms/*diagnostic imaging bladder cancer diagnostic accuracy magnetic resonance imaging staging systematic review